<?xml version="1.0" encoding="ISO-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://www.humangrowthhormones.biz/feed/zorbtive.xml/">
        <title>Human Growth Hormones</title>
        <description>'Zorbtive'</description>
        <link>http://www.humangrowthhormones.biz/zorbtive.xml/</link>
       <dc:date>2008-11-20T18:51:49+01:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#business-wire----rodman-&amp;amp;-renshaw-3rd-annual-global-healthcare-conference-2006-presenter-profiles"/>
                <rdf:li rdf:resource="http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#worldwide-biotech----serono's-gonal-f-approved-in-japan-for-hypogonadism"/>
                <rdf:li rdf:resource="http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#business-wire----serono-and-ivax-announce-positive-outcome-of-pharmacokinetic-trials-with-oral-cladribine"/>
            </rdf:Seq>
        </items>
    </channel>
    <item rdf:about="http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#business-wire----rodman-&amp;amp;-renshaw-3rd-annual-global-healthcare-conference-2006-presenter-profiles">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Rodman &amp;amp;amp; Renshaw 3rd Annual Global Healthcare Conference 2006 Presenter Profiles</title>
        <link>http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#business-wire----rodman-&amp;amp;-renshaw-3rd-annual-global-healthcare-conference-2006-presenter-profiles</link>
        <description>May 12, 2006 -- MONTE CARLO, Monaco -- Rodman &amp;amp; Renshaw 3rd Annual Global Healthcare Conference 2006 takes place May 15-16 in Monte Carlo.   For in-depth...</description>
    </item>
    <item rdf:about="http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#worldwide-biotech----serono's-gonal-f-approved-in-japan-for-hypogonadism">
        <dc:format>text/html</dc:format>
        <title>Worldwide Biotech -  Serono's Gonal-F Approved In Japan For Hypogonadism</title>
        <link>http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#worldwide-biotech----serono's-gonal-f-approved-in-japan-for-hypogonadism</link>
        <description>March 1, 2006 -- Serono (virt-x: SEO and NYSE: SRA) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Gonal-f(R) 75 IU and...</description>
    </item>
    <item rdf:about="http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#business-wire----serono-and-ivax-announce-positive-outcome-of-pharmacokinetic-trials-with-oral-cladribine">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Serono and IVAX Announce Positive Outcome of Pharmacokinetic Trials with Oral Cladribine</title>
        <link>http://www.humangrowthhormones.biz/human-growth-hormone/zorbtive.xml/#business-wire----serono-and-ivax-announce-positive-outcome-of-pharmacokinetic-trials-with-oral-cladribine</link>
        <description>March 23, 2004 -- Business Editors/Health/Medical Writers   GENEVA &amp;amp; MIAMI--(BUSINESS WIRE)--March 23, 2004   Cladribine Targeted to Become First Oral Therapy for...</description>
    </item>
</rdf:RDF>
